{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:41:47Z","timestamp":1791988907021,"version":"4.4.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.prp.2024.155785","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T03:10:23Z","timestamp":1734577823000},"page":"155785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing"],"prefix":"10.1016","volume":"266","author":[{"given":"Ashok Kumar","family":"Balaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Arockia","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehssan","family":"Moglad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viralkumar","family":"Mandaliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.V. Siva","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155785_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","article-title":"CRISPR-Cas9 for cancer therapy: opportunities and challenges","volume":"447","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"5819","key":"10.1016\/j.prp.2024.155785_bib2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Sander","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"6213","key":"10.1016\/j.prp.2024.155785_bib4","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"issue":"7536","key":"10.1016\/j.prp.2024.155785_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"issue":"6096","key":"10.1016\/j.prp.2024.155785_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.prp.2024.155785_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.prp.2024.155785_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.prp.2024.155785_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/vim.2024.0026","article-title":"Noncoding RNAs in the COVID-19 Saga: an untold story","volume":"37","author":"Maqbool","year":"2024","journal-title":"Viral Immunol."},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.prp.2024.155785_bib11","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for Nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.prp.2024.155785_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd.2016.280","article-title":"Delivery technologies for genome editing","volume":"16","author":"Yin","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2024.155785_bib13","article-title":"Exosomal ncRNAs in liquid biopsies for lung cancer","volume":"565","author":"Sadique Hussain","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"6478","key":"10.1016\/j.prp.2024.155785_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib15","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00280.2019","article-title":"Extracellular vesicles as biomarkers and therapeutic targets for cancer","volume":"318","author":"Urabe","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"Pt A","key":"10.1016\/j.prp.2024.155785_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7659","key":"10.1016\/j.prp.2024.155785_bib17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2024.155785_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.prp.2024.155785_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101649","article-title":"CRISPR\/Cas9 delivery system engineering for genome editing in therapeutic applications","volume":"13","author":"Cheng","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nmeth.2681","article-title":"Orthogonal Cas9 proteins for RNA-guided gene regulation and editing","volume":"10","author":"Esvelt","year":"2013","journal-title":"Nat. Methods"},{"issue":"39","key":"10.1016\/j.prp.2024.155785_bib21","doi-asserted-by":"crossref","first-page":"15644","DOI":"10.1073\/pnas.1313587110","article-title":"Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis","volume":"110","author":"Hou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.tibtech.2022.12.022","article-title":"The genome editing revolution","volume":"41","author":"van der Oost","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib23","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1038\/s41467-022-30515-0","article-title":"CRISPR\/Cas9 gRNA activity depends on free energy changes and on the target PAM context","volume":"13","author":"Corsi","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib24","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41467-022-31543-6","article-title":"Massively targeted evaluation of therapeutic CRISPR off-targets in cells","volume":"13","author":"Pan","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib25","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1038\/s41467-021-23576-0","article-title":"Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning","volume":"12","author":"Xiang","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.prp.2024.155785_bib26","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci. Alliance"},{"issue":"5","key":"10.1016\/j.prp.2024.155785_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1089\/crispr.2022.0051","article-title":"Advances in CRISPR delivery methods: perspectives and challenges","volume":"5","author":"Demirci","year":"2022","journal-title":"Crispr J."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"issue":"8","key":"10.1016\/j.prp.2024.155785_bib29","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.prp.2024.155785_bib30","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acssynbio.8b00192","article-title":"Delivery of an artificial transcription regulator dCas9-VPR by extracellular vesicles for therapeutic gene activation","volume":"7","author":"Lain\u0161\u010dek","year":"2018","journal-title":"ACS Synth. Biol."},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/giy011","article-title":"Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases","volume":"7","author":"Lin","year":"2018","journal-title":"Gigascience"},{"key":"10.1016\/j.prp.2024.155785_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118525","article-title":"CRISPR\/Cas9: a powerful genome editing technique for the treatment of cancer cells with present challenges and future directions","volume":"263","author":"Hazafa","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2024.155785_bib33","doi-asserted-by":"crossref","DOI":"10.1109\/TCBB.2024.3459870","article-title":"GenoM7GNet: an efficient N(7)-methylguanosine site prediction approach based on a nucleotide language model","author":"Li","year":"2024","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinf."},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/09205063.2022.2121592","article-title":"Lipid-based nanocarrier mediated CRISPR\/Cas9 delivery for cancer therapy","volume":"34","author":"Aziz","year":"2023","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.prp.2024.155785_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126559","article-title":"In-situ monitoring of cellular H(2)O(2) within 3D cell clusters using conductive scaffolds","volume":"279","author":"Zhu","year":"2024","journal-title":"Talanta"},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116072","article-title":"CRISPR\/Cas9: principle, applications, and delivery through extracellular vesicles","volume":"22","author":"Horodecka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.prp.2024.155785_bib37","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/cbic.202100359","article-title":"Exosomes as targeted delivery platform of CRISPR\/Cas9 for therapeutic genome editing","volume":"22","author":"Duan","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.prp.2024.155785_bib38","article-title":"sc2GWAS: a comprehensive platform linking single cell and GWAS traits of human","author":"Yin","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2024.155785_bib39","article-title":"Exosomes for CRISPR-Cas9 delivery: the cutting edge in genome editing","author":"Aslan","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.prp.2024.155785_bib40","article-title":"scImmOmics: a manually curated resource of single-cell multi-omics immune data","author":"Li","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.prp.2024.155785_bib41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.56434\/j.arch.esp.urol.20237607.62","article-title":"Metabolic syndrome is associated with prostate cancer diagnosed on biopsy but not the Gleason score and the number of cancer-positive cores: a prospective controlled study","volume":"76","author":"Bayraktar","year":"2023","journal-title":"Arch. Esp. Urol."},{"key":"10.1016\/j.prp.2024.155785_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jconrel.2022.06.011","article-title":"Recent progresses in exosome-based systems for targeted drug delivery to the brain","volume":"348","author":"Bashyal","year":"2022","journal-title":"J. Control Release"},{"issue":"7","key":"10.1016\/j.prp.2024.155785_bib43","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.7150\/jca.91546","article-title":"Identification of a lncRNA\/circRNA-miRNA-mRNA network in Nasopharyngeal carcinoma by deep sequencing and bioinformatics analysis","volume":"15","author":"Liu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2024.155785_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","article-title":"Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting","volume":"266","author":"Kim","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.prp.2024.155785_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119513","article-title":"Metal organic framework coated MnO(2) nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer","volume":"585","author":"Nie","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib46","doi-asserted-by":"crossref","first-page":"1700611","DOI":"10.1002\/advs.201700611","article-title":"Exosome-liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs","volume":"5","author":"Lin","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.prp.2024.155785_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2018.10.023","article-title":"Calcitonin gene-related peptide inhibits the cardiac fibroblasts senescence in cardiac fibrosis via up-regulating klotho expression","volume":"843","author":"Li","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib48","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","article-title":"Efficient RNA drug delivery using red blood cell extracellular vesicles","volume":"9","author":"Usman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155785_bib49","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.2147\/DDDT.S282206","article-title":"Xanthohumol inhibits TGF-\u03b21-induced cardiac fibroblasts activation via mediating PTEN\/Akt\/mTOR signaling pathway","volume":"14","author":"Jiang","year":"2020","journal-title":"Drug Des. Dev.\u00a0Ther."},{"key":"10.1016\/j.prp.2024.155785_bib50","first-page":"80","article-title":"Isolation and analysis methods of extracellular vesicles (EVs). Extracell vesicles","volume":"2","author":"Zhao","year":"2021","journal-title":"Circ. Nucl. Acids"},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.prp.2024.155785_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102121","article-title":"A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications","volume":"50","author":"Dilsiz","year":"2024","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1568009623666230817102104","article-title":"Mirna-383-5p functions as an anti-oncogene in glioma through the Akt\/mTOR signaling pathway by targeting VEGFA","volume":"24","author":"Liu","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib54","first-page":"872","article-title":"A deniable encryption method for modulation-based DNA storage","volume":"16","author":"Chu","year":"2024","journal-title":"Inter. Sci."},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib55","first-page":"419","article-title":"A novel image encryption scheme for DNA storage systems based on DNA hybridization and gene mutation","volume":"15","author":"Yao","year":"2023","journal-title":"Inter. Sci."},{"key":"10.1016\/j.prp.2024.155785_bib56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.omtn.2019.05.032","article-title":"Activation of necroptosis by engineered self tumor-derived exosomes loaded with CRISPR\/Cas9","volume":"17","author":"Gulei","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.0409141102","article-title":"Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter","volume":"102","author":"Su","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.prp.2024.155785_bib59","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1039\/D0BM00427H","article-title":"An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells","volume":"8","author":"Ye","year":"2020","journal-title":"Biomater. Sci."},{"issue":"16","key":"10.1016\/j.prp.2024.155785_bib60","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1093\/nar\/gkaa683","article-title":"Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR\/Cas9 system for gene therapy","volume":"48","author":"Zhuang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.prp.2024.155785_bib61","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2024.155785_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221085370","article-title":"In vivo visualized tracking of tumor-derived extracellular vesicles using CRISPR-Cas9 system","volume":"21","author":"Ye","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"issue":"15","key":"10.1016\/j.prp.2024.155785_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/polym13152529","article-title":"A comprehensive review on the applications of exosomes and liposomes in regenerative medicine and tissue engineering","volume":"13","author":"Shafiei","year":"2021","journal-title":"Polymers"},{"issue":"5","key":"10.1016\/j.prp.2024.155785_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization","volume":"11","author":"van der Koog","year":"2022","journal-title":"Adv. Health Mater."},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib65","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41401-022-00902-w","article-title":"Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy","volume":"43","author":"Mukherjee","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202217089","article-title":"In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes","volume":"62","author":"Zhang","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2024.155785_bib69","doi-asserted-by":"crossref","first-page":"1447953","DOI":"10.3389\/fmolb.2024.1447953","article-title":"Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges","volume":"11","author":"Ubanako","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"9","key":"10.1016\/j.prp.2024.155785_bib70","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1021\/acs.molpharmaceut.8b00277","article-title":"Exosomes as a drug delivery system in cancer therapy: potential and challenges","volume":"15","author":"Kibria","year":"2018","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.prp.2024.155785_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092053","article-title":"The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155785_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.764222","article-title":"Exosome-mediated crosstalk between tumor and tumor-associated macrophages","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-023-01408-6","article-title":"Protein cargo in extracellular vesicles as the key mediator in the progression of cancer","volume":"22","author":"H\u00e1n\u011blov\u00e1","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s10020-023-00665-y","article-title":"Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment","volume":"29","author":"Peng","year":"2023","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12951-024-02298-7","article-title":"Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib76","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s12967-024-05570-4","article-title":"Harnessing the evolving CRISPR\/Cas9 for precision oncology","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40164-024-00570-y","article-title":"CRISPR\/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications","volume":"13","author":"Feng","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.prp.2024.155785_bib78","doi-asserted-by":"crossref","DOI":"10.1039\/D4NA00501E","article-title":"A comprehensive review of challenges and advances in exosome-based drug delivery systems","author":"Palakurthi","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"22","key":"10.1016\/j.prp.2024.155785_bib79","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.7150\/thno.49047","article-title":"An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification","volume":"10","author":"Xing","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib80","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41467-020-14977-8","article-title":"A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA","volume":"11","author":"de Jong","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.prp.2024.155785_bib81","doi-asserted-by":"crossref","first-page":"2000093","DOI":"10.1002\/adtp.202000093","article-title":"Applying CRISPR\/Cas13 to construct Exosomal PD-L1 Ultrasensitive Biosensors for dynamic monitoring of tumor progression in Immunotherapy","volume":"3","author":"He","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.prp.2024.155785_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114324","article-title":"The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system","volume":"187","author":"Jiang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib83","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.prp.2024.155785_bib84","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery aspects of CRISPR\/Cas for in vivo genome editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"6","key":"10.1016\/j.prp.2024.155785_bib85","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.prp.2024.155785_bib86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12033-023-00724-z","article-title":"An update on the application of CRISPR technology in clinical practice","volume":"66","author":"Morshedzadeh","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"2","key":"10.1016\/j.prp.2024.155785_bib87","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41409-019-0616-z","article-title":"Mesenchymal stem cell-derived exosomes for clinical use","volume":"54","author":"Mendt","year":"2019","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.prp.2024.155785_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112624","article-title":"Spinal cord injury target-immunotherapy with TNF-\u03b1 autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR\/Cas9 plasmid","volume":"133","author":"Wang","year":"2022","journal-title":"Biomater. Adv."},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib89","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.2015.995086","article-title":"Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process","volume":"15","author":"Liu","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"30","key":"10.1016\/j.prp.2024.155785_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202312153","article-title":"Nanoplatform-based in vivo gene delivery systems for cancer therapy","volume":"20","author":"Luo","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.prp.2024.155785_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113930","article-title":"Advances in mRNA non-viral delivery approaches","volume":"177","author":"Ibba","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib92","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/hum.2018.069","article-title":"Clinical evaluations of toxicity and efficacy of nanoparticle-mediated gene therapy","volume":"29","author":"Liang","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"7-8","key":"10.1016\/j.prp.2024.155785_bib93","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41417-019-0141-7","article-title":"Liposomal delivery of CRISPR\/Cas9","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040851","article-title":"Targeting and crossing the blood-brain barrier with extracellular vesicles","volume":"9","author":"Saint-Pol","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib95","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12951-023-01952-w","article-title":"Current and prospective strategies for advancing the targeted delivery of CRISPR\/Cas system via extracellular vesicles","volume":"21","author":"Huang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","article-title":"Exosome engineering in cell therapy and drug delivery","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prp.2024.155785_bib97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.21775\/cimb.026.065","article-title":"Improving CRISPR-Cas9 on-target specificity","volume":"26","author":"Jamal","year":"2018","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.prp.2024.155785_bib98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcell.2020.00376","article-title":"Cloaked viruses and viral factors in cutting edge exosome-based therapies","volume":"8","author":"Dogrammatzis","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.prp.2024.155785_bib99","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.prp.2024.155785_bib100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.phrs.2016.07.006","article-title":"Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: new nanotools for cancer treatment","volume":"111","author":"Kooijmans","year":"2016","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41551-023-01150-x","article-title":"Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons","volume":"8","author":"Gu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.prp.2024.155785_bib102","doi-asserted-by":"crossref","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. Extra Vesicles"},{"issue":"7","key":"10.1016\/j.prp.2024.155785_bib103","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.prp.2024.155785_bib104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.prp.2024.155785_bib105","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"issue":"13","key":"10.1016\/j.prp.2024.155785_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201605604","article-title":"Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes","volume":"29","author":"Yang","year":"2017","journal-title":"Adv. Mater."},{"issue":"33","key":"10.1016\/j.prp.2024.155785_bib107","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.2174\/0929867325666180831150259","article-title":"Exosome-like nanovectors for drug delivery in cancer","volume":"26","author":"Arrighetti","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2024.155785_bib108","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.2147\/IJN.S225453","article-title":"Extracellular vesicles as nanomedicine: hopes and hurdles in clinical translation","volume":"14","author":"Burnouf","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib109","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","article-title":"Engineered exosomes from different sources for cancer-targeted therapy","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.prp.2024.155785_bib110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10142-023-01117-w","article-title":"A review on CRISPR\/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment","volume":"23","author":"Yang","year":"2023","journal-title":"Funct. Integr. Genom."},{"issue":"11","key":"10.1016\/j.prp.2024.155785_bib111","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1021\/acs.bioconjchem.0c00483","article-title":"Anchor, spacer, and ligand-modified engineered exosomes for trackable targeted therapy","volume":"31","author":"Kang","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"7","key":"10.1016\/j.prp.2024.155785_bib112","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"issue":"3-4","key":"10.1016\/j.prp.2024.155785_bib113","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41417-019-0131-9","article-title":"Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2024.155785_bib114","article-title":"Effect of CRISPR\/Cas9-Edited PD-1\/PD-L1 on tumor immunity and immunotherapy","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2024.155785_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020326","article-title":"CRISPR-Cas9 screen identifies DYRK1A as a target for radiotherapy sensitization in pancreatic cancer","volume":"14","author":"Lan","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2024.155785_bib116","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1039\/D0NR07622H","article-title":"Exosome-mediated delivery of gene vectors for gene therapy","volume":"13","author":"Duan","year":"2021","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib117","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12943-022-01565-1","article-title":"CRISPR\/Cas9 and next generation sequencing in the personalized treatment of Cancer","volume":"21","author":"Selvakumar","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155785_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300359","article-title":"Recent progress in prompt molecular detection of exosomes using CRISPR\/Cas and microfluidic-assisted approaches toward smart cancer diagnosis and analysis","volume":"19","author":"Mojtaba Mousavi","year":"2024","journal-title":"ChemMedChem"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T06:33:02Z","timestamp":1739255582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824006964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":118,"alternative-id":["S0344033824006964"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155785","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155785"}}